Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome

Annals of Nutrition and Metabolism

Volumn 62, Issue 1, 2013, Pages 80-85

  Bene, Judit ^a   Márton, Magdolna ^a   Mohás, Márton ^b   Bagosi, Zoltán ^c   Bujtor, Zoltán ^c   Oroszlán, Tamás ^c   Gasztonyi, Beáta ^c   Wittmann, Istvan ^b   Melegh, Bela ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Zala County Hospital   (Hungary)

Author keywords

Carnitine ester profile; Diabetes mellitus; Mass spectrometry; Metabolic syndrome

Indexed keywords

ACYLCARNITINE; CARNITINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; ELECTROSPRAY MASS SPECTROMETRY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE DILUTION ASSAY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; BODY MASS;

ADULT; AGED; BODY MASS INDEX; CARNITINE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84871880240     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000345759     Document Type: Article

References (31)

1. Bieber LL: Carnitine. Annu Rev Biochem 1988; 57: 261-283.
2. Proulx F, Lacroix J, Qureshi IA, Nadeau D, Gauthier M, Lambert M: Acquired carnitine abnormalities in critically ill children. Eur J Pediatr 1997; 156: 864-869.
3. Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del CD, Oleggini M, Brandi L, Mac-cari F: Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 1988; 255:E946-E952.
4. Capaldo B, Napoli R, Di BP, Albano G, Sacca L: Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 1991; 14: 191-195.
5. Genuth SM, Hoppel CL: Plasma and urine carnitine in diabetic ketosis. Diabetes 1979; 28: 1083-1087.
6. De PE, Gatti R, Sicolo N, Padovan D, Vettor R, Federspil G: Plasma and urine free L-car-nitine in human diabetes mellitus. Acta Dia-betol Lat 1981; 18: 91-95.
7. Okuda Y, Kawai K, Murayama Y, Yamashita K: Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulin-dependent diabetic subjects. Endo-crinol Jpn 1987; 34: 415-422.
8. Pregant P, Kaiser E, Schernthaner G: No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients. Clin Investig 1993; 71: 610-612.
9. Tamamogullari N, Silig Y, Icagasioglu S, At-alay A: Carnitine deficiency in diabetes mel-litus complications. J Diabetes Complications 1999; 13: 251-253.
10. Poorabbas A, Fallah F, Bagdadchi J, Mahdavi R, Aliasgarzadeh A, Asadi Y, Koushavar H, Vahed JM: Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr 2007; 61: 892-895.
11. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, Minkler PE, Hwang DH, Newman JW, Garvey WT: Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 2009; 139: 1073-1081.
12. Cederblad G, Hermansson G, Ludvigsson J: Plasma and urine carnitine in children with diabetes mellitus. Clin Chim Acta 1982; 125: 207-217.
13. Soltesz G, Melegh B, Sandor A: The relationship between carnitine and ketone body levels in diabetic children. Acta Paediatr Scand 1983; 72: 511-515.
14. Winter SC, Simon M, Zorn EM, Szabo-Aczel S, Vance WH, O'Hara T, Higashi L: Relative carnitine insufficiency in children with type I diabetes mellitus. Am J Dis Child 1989; 143: 1337-1339.
15. Mamoulakis D, Galanakis E, Dionyssopou-lou E, Evangeliou A, Sbyrakis S: Carnitine deficiency in children and adolescents with type 1 diabetes. J Diabetes Complications 2004; 18: 271-274.
16. Möder M, Kiessling A, Loster H, Brugge-mann L: The pattern of urinary acylcarni-tines determined by electrospray mass spec-trometry: a new tool in the diagnosis of diabetes mellitus. Anal Bioanal Chem 2003; 375: 200-210.
17. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FG, DeLany JP: Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identifica-t ion of a ma rker of g lucol ip otox icit y. Obesity (Silver Spring) 2010; 18: 1695-1700.
18. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Ar-lotto M, Slentz CA, Rochon J, Gallup D, Il-kayeva O, Wenner BR, Yancy WS Jr, Eisen-son H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9: 311-326.
19. Costa CC, de Almeida IT, Jakobs C, Poll-The BT, Duran M: Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pe-diatr Res 1999; 46: 440-444.
20. Bene J, Komlosi K, Magyari L, Talian G, Horvath K, Gasztonyi B, Miheller P, Figler M, Mozsik G, Tulassay Z, Melegh B: Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. Br J Nutr 2007; 98: 345-350.
21. Hoppel C: The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 2003; 41:S4-S12.
22. Melegh B, Kerner J, Sandor A, Vinceller M, Kispal G: Effects of oral L-carnitine supplementation in low-birth-weight premature infants maintained on human milk. Biol Ne-onate 1987; 51: 185-193.
23. Melegh B, Pap M, Morava E, Molnar D, Dani M, Kurucz J: Carnitine-dependent changes of metabolic fuel consumption during long-term treatment with valproic acid. J Pediatr 1994; 125: 317-321.
24. Vaz FM, Melegh B, Bene J, Cuebas D, Gage DA, Bootsma A, Vreken P, van Gennip AH, Bieber LL, Wanders RJ: Analysis of carnitine biosynthesis metabolites in urine by HPLC-electrospray tandem mass spectrometry. Clin Chem 2002; 48: 826-834.
25. Melegh B, Kerner J, Acsadi G, Lakatos J, Sandor A: L-carnitine replacement therapy in chronic valproate treatment. Neuropediat-rics 1990; 21: 40-43.
26. Calvani M, Reda E, Arrigoni-Martelli E: Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol 2000; 95: 75-83.
27. Millington DS, Kodo N, Norwood DL, Roe CR: Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990; 13: 321-324.
28. Chace DH, Hillman SL, Van Hove JL, Naylor EW: Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 1997; 43: 2106-2113.
29. Rashed MS: Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chromatogr B Biomed Sci Appl 2001; 758: 27-48.
30. McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997; 244: 1-14.
31. Gaster M: Reduced TCA flux in diabetic myotubes: a governing influence on the diabetic phenotype? Biochem Biophys Res Commun 2009; 387: 651-655.